research Telogen Effluvium in Patients recovering from COVID-19
Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.
Search
for
Sort by
Research
90-120 / 1000+ results 
research A hair loss pandemic: 19 cases of COVID-19 induced telogen effluvium
COVID-19 can cause hair loss in both severe and mild cases, often affecting women.
research Telogen Effluvium After COVID-19 Infection: A Case Report
COVID-19 infection may cause hair loss a few months after recovery.
research Telogen effluvium in covid-19 patients: a cross-sectional survey
COVID-19 often causes hair loss, especially in women.
research Telogen effluvium and COVID-19: a cross-sectional study.
COVID-19 infection is highly related to increased hair loss, especially in women.
research Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia
Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.
research Relationship Between Anemia and Telogen Effluvium in Post-COVID-19 Survivors
Anemia increases the risk of hair loss in post-COVID-19 survivors.
research CARACTERÍSTICAS CLÍNICAS E EPIDEMIOLÓGICAS DO EFLÚVIO TELÓGENO PÓS COVID-19
COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.
research Efficacy of Dr. SKS hair booster serum for the treatment of hair loss in COVID-19 induced persistent telogen effluvium
Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.
research Evaluation of the Relationship between Favipiravir Use Status and Telogen Effluvium in Patients Diagnosed with COVID-19
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research IMPACTOS CAPILARES DA COVID-19 A LIGAÇÃO ENTRE EFLÚVIO TELÓGENO AGUDO E ALOPECIA AREATA: REVISÃO INTEGRATIVA
Covid-19 can cause hair loss due to immune and psychological factors.
research Telogen Effluvium and COVID-19: a case and a brief review of literature
COVID-19 may cause temporary hair loss due to the body's immune response.
research Homoeopathy in Covid 19 Sequelae: A Case of Telogen Effluvium
Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.
research Red nail bands in conjunction with telogen effluvium as a post‐COVID‐19 phenomenon
Red stripes on nails and hair loss may occur after COVID-19.
research Efficacy of QR678 Neo® hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.
research Hair loss in women
Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.
research Covid induced telogen effluvium (CITE): An insight
COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.
research Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.
research Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.
research Telogen effluvium in the new SARS‐CoV‐2 era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Casos de eflúvio telógeno em pacientes pós-infecção pelo Covid-19 na cidade de Guanambi – Bahia: incidência e manejo
COVID-19 may trigger hair loss in some people.
research SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research CARACTERÍSTICAS CLÍNICAS DO EFLÚVIO TELÓGENO INDUZIDO PELA INFECÇÃO DE COVID-19: REVISÃO INTEGRATIVA
COVID-19 can cause intense hair loss in women, usually resolving in 1 to 4 months.
research Telogen effluvium related to post severe Sars‐Cov‐2 infection: Clinical aspects and our management experience
Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.
research Hair Loss and Androgen’s Role in the Era of COVID-19
Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.
research Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization
COVID-19 can cause hair loss starting as early as 18 days after infection.
research Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
COVID-19 can cause or worsen skin conditions and might show early signs of infection.
research Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
COVID-19 can cause different skin issues, including rashes and hair loss.
research Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.
research Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends (Preprint)
Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.